Skip to main content

Table 1 Patients characteristic for the presence of plaque

From: Lower ratio of high-molecular-weight adiponectin level to total may be associated with coronary high-risk plaque

 

Plaque (−)

Plaque (+)

P value

 

Total plaque

 

Male/Female

6/4

31/12

0.45

Age (years)

71.4±8.7

70.7±8.6

0.80

Smoking (%)

50

42

0.64

Diabetes mellitus (%)

40

47

0.71

Hypertension (%)

78

89

0.34

Glucose (mg/dL)

110.0 (100.0-176.0)

116 (99.0-144.0)

0.50

LDL-Cholesterol (mg/dL)

88.5 (84.0-137.0)

108.0 (95.0-127.0)

0.35

HDL-Cholesterol (mg/dL)

59.0 (46.0-64.0)

47.0 (42.0-55.0)

0.02

Triglyceride (mg/dL)

114.5 (88.0-192.0)

132.0 (99.0-222.0)

0.50

HbA1c (mg/dL)

5.3 (4.9-6.5)

5.6 (5.1-6.5)

0.48

HOMA-IR

2.0 (1.5-8.8)

2.6 (1.6-7.9)

0.70

hsCRP (mg/dL)

0.03 (0.02-0.09)

0.06 (0.03-0.12)

0.12

BMI (kg/m2)

23.08±2.7

24.0±2.9

0.40

 

Low attenuation plaque

 

Male/Female

15/10

16/2

0.04

Age (years)

69.1±9.3

71.8±8.12

0.34

Smoking (%)

36

50

0.36

Diabetes mellitus (%)

44

50

0.70

Hypertension (%)

91

87

0.65

Glucose (mg/dL)

108.0 (100.0-139.0)

119.0 (94.0-148.0)

0.89

LDL-Cholesterol (mg/dL)

110.0 (99.0-132.0)

106.0 (85.0-127.0)

0.47

HDL-Cholesterol (mg/dL)

106.0 (85.0-127.0)

48.5 (42.0-56.0)

0.67

Triglyceride (mg/dL)

126.0 (94.0-222.0)

134.0 (115.0-195.0)

0.70

HbA1c (mg/dL)

5.5 (5.2-6.2)

6.2 (5.0-7.0)

0.82

HOMA-IR

2.4 (1.2-7.9)

4.0 (1.8-6.7)

0.30

hsCRP (mg/dL)

0.04 (0.03-0.10)

0.06 (0.03-0.12)

0.83

BMI (kg/m2)

23.06±2.5

24.06±2.8

0.46

  1. LDL, low density lipoprotein; HDL, high density lipoprotein; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; BMI, body mass index.